Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong
· Delayed Price · Currency is HKD 36.60
+2.35 (6.86%)
May 13, 2025, 4:08 PM HKT
Shanghai Henlius Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | 820.47 | 546.02 | -695.26 | -984.05 | -993.54 | Upgrade
|
| Depreciation & Amortization | 367.24 | 353.32 | 273.12 | 196.56 | 133.43 | Upgrade
|
| Other Amortization | 7.56 | 5.91 | 4.48 | 32.62 | 5.79 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.82 | -0.72 | 0.25 | 0.93 | -0.81 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | -0.01 | Upgrade
|
| Stock-Based Compensation | - | 2.59 | 12.52 | 48.42 | 35.73 | Upgrade
|
| Provision & Write-off of Bad Debts | -5.03 | 9.03 | 1.64 | 0.17 | - | Upgrade
|
| Other Operating Activities | 109.11 | 152.88 | 284.19 | 284.61 | 94.17 | Upgrade
|
| Change in Accounts Receivable | -165.95 | -283.77 | -161.41 | -99.7 | -340.94 | Upgrade
|
| Change in Inventory | 23.86 | -22.34 | -340.64 | -91.71 | -53.73 | Upgrade
|
| Change in Accounts Payable | 161.37 | -108.34 | 312.56 | 20.04 | 145.76 | Upgrade
|
| Change in Unearned Revenue | 120.24 | 495.12 | 227.14 | 303.83 | 217.6 | Upgrade
|
| Change in Other Net Operating Assets | -196.15 | -101.78 | 1,063 | 378.68 | 146.97 | Upgrade
|
| Operating Cash Flow | 1,242 | 1,048 | 981.62 | 90.39 | -609.58 | Upgrade
|
| Operating Cash Flow Growth | 18.51% | 6.75% | 985.96% | - | - | Upgrade
|
| Capital Expenditures | -164.01 | -473.67 | -584.97 | -460.43 | -557 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.24 | 0.02 | 6.56 | 0.55 | 0.27 | Upgrade
|
| Cash Acquisitions | - | -15 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -673.2 | -537.77 | -780.32 | -670.76 | -955.52 | Upgrade
|
| Investment in Securities | -73 | -120 | - | - | - | Upgrade
|
| Other Investing Activities | - | 141.98 | - | -550.61 | - | Upgrade
|
| Investing Cash Flow | -909.97 | -1,004 | -1,359 | -1,681 | -1,512 | Upgrade
|
| Long-Term Debt Issued | 2,674 | 2,512 | 2,859 | 2,096 | 1,443 | Upgrade
|
| Total Debt Issued | 2,674 | 2,512 | 2,859 | 2,096 | 1,443 | Upgrade
|
| Long-Term Debt Repaid | -3,184 | -2,237 | -1,886 | -1,364 | -392.54 | Upgrade
|
| Total Debt Repaid | -3,184 | -2,237 | -1,886 | -1,364 | -392.54 | Upgrade
|
| Net Debt Issued (Repaid) | -510.34 | 274.34 | 972.77 | 731.67 | 1,050 | Upgrade
|
| Other Financing Activities | -133.03 | -129.91 | -114.75 | -83.36 | -54.66 | Upgrade
|
| Financing Cash Flow | -643.37 | 144.43 | 858.02 | 648.3 | 995.79 | Upgrade
|
| Foreign Exchange Rate Adjustments | 15.18 | 6.27 | 37.59 | -16.77 | -60.75 | Upgrade
|
| Net Cash Flow | -296.26 | 194.19 | 518.49 | -959.33 | -1,187 | Upgrade
|
| Free Cash Flow | 1,078 | 574.25 | 396.65 | -370.04 | -1,167 | Upgrade
|
| Free Cash Flow Growth | 87.70% | 44.77% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 18.83% | 10.64% | 12.34% | -21.99% | -198.54% | Upgrade
|
| Free Cash Flow Per Share | 1.98 | 1.06 | 0.73 | -0.69 | -2.20 | Upgrade
|
| Cash Interest Paid | 133.03 | 129.91 | 114.75 | 83.2 | 28.34 | Upgrade
|
| Cash Income Tax Paid | 28.26 | 20.71 | 1.37 | - | - | Upgrade
|
| Levered Free Cash Flow | 176.66 | -709.99 | -1,019 | -857.51 | -2,271 | Upgrade
|
| Unlevered Free Cash Flow | 253.46 | -640.9 | -952.46 | -804.5 | -2,243 | Upgrade
|
| Change in Net Working Capital | -174.31 | 399.37 | -515.54 | -464.88 | 327.7 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.